FDA warns duodenoscope makers about postmarket surveillance


The FDA issued warning letters to all three duodenoscope manufacturers – Olympus, Fujifilm, and Pentax -- for failing to comply with federal orders requiring them to conduct postmarket surveillance studies to assess the effectiveness of reprocessing the devices. Read the FDA news release.

<< return to Advocacy Updates